Satiety fills up on $25.3M for obesity treatments
Satiety, maker of a minimally-invasive medical device that reduces obesity, has raised $25.3 million of an anticipated $33 million round of equity and rights, according to a filing with the SEC. The Palo Alto, Calif. company was previously backed by HLM Venture Partners, Morgenthaler Ventures, Pinnacle Ventures, Skyline Ventures, Thomas Fogarty, Three Arch Partners and Venrock. It has raised four rounds of funding to date, not including a $7.5 million bridge loan from its investors brought in early this year.
Next Story: DFJ, Claremont invest $6.5M in out-of-home ad network
Previous Story: Financial reporting software maker HyperRoll sells off assets to Oracle
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.